Magnetic Resonance Imaging of the Breast
Download
Report
Transcript Magnetic Resonance Imaging of the Breast
Magnetic Resonance
Imaging of the Breast
Dr.Bushra F Ali
Consultant radiologist
Al-Khansa Teaching hospital
• Basic MRI Technology
• The basic MR system is composed of a
main magnetic field, gradient fields, RF
pulse generators, radiofrequency antennas
to receive the signals returning from the
tissues, and computer systems to control
the system and to convert the information
into readable images.
• Some favor evaluating images in the
axial planes, others choose to
interpret in the sagittal plane.
• A dedicated breast coil, at least 1.5Tesla magnet strength, and dynamic
contrast administration are absolute
requirements for the performance of
breast MRI.
• Many early breast imaging systems
used a single coil and only one breast
could be imaged at a time.
• We have always preferred a double
coil that allowed bilateral simultaneous
imaging because it has permitted a
direct comparison between the two
breasts.
standards for the performance of breast MRI
The fat have faster relaxation times
(greater interaction between
molecules), so their T1 signal is shorter
than pure water; thus, fat has the
shortest T1 relaxation time. By
convention, tissues with short T1 are
presented as bright signals on T1
images.
• Signals from Water: tissues with a
long T2 are presented as bright
signals on T2-weighted images. Thus,
cysts (that contain fluid) with long T1
are dark on T1-weighted images and
those with long T2 are bright on T2weighted images.
On MRI this cyst had a characteristically low
signal intensity (black) on this T1-weighted image
(A) and a high signal intensity (white) on the T2weighted image (B).
• FAT Suppression :
• Because of the high signal intensity of fat
on T1 images, it is often difficult to
appreciate enhancing lesions on gradientecho images from the high signal
produced by fat on T1-weighted images.
Consequently, methods have been
devised that eliminate the high signal from
fat so that the tissues that enhance
following contrast administration are more
easily appreciated .
• Most MRI includes sequences that
suppress the signal from fat. To
optimize the chemical-shift fatsuppression techniques, maximizing
the homogeneity of the field of the
imaging volume is necessary.
Shimming before imaging is needed to
reduce the field in homogeneities that
commonly occur in breast imaging.
• Automated shimming is available.
One effective method of fat
suppression that is used in the one
dedicated breast MRI system being
sold uses RODEO (rotating delivery of
excitation off-resonance) pulse
sequence.
Fat suppression makes enhancing lesions easier to appreciate. Fat has low
signal intensity on this fat-saturated T1-weighted image (A) prior to the IV
administration of contrast. The cancer in the left breast is more evident on the
first fat-saturated set of images following contrast injection (B). The lesion is
more evident on this maximum intensity contrast subtraction 3D display (C) and
on this single-slice subtraction image (D).
• The most important advantage of
breast MRI at this time is that contrast
enhancement makes lesions stand out
from the background tissues (high
signal to background).
• Unlike mammography and US, where
the signals generated by cancer may
be similar to the background tissue,
thus making the lesion difficult to
perceive or even invisible on those
tests.
• Using contrast enhancement, MRI of the breast
has become an increasingly useful clinical test.
• MRI of the breast requires the use of an (IV)
contrast agent to define areas of possible
malignancy.
• There is no data to support the use of MRI as a
screening tool.
• Screening mammography generally used to
detect breast cancer in the general population.
while breast MRI has been shown to detect an
increased rate of small cancers in women at
high risk for breast cancer.
Fibroadenomas are usually round or oval,
with sharply defined margins, on contrastenhanced MRI.
• The normal axillary lymph nodes also
routinely enhance .
• The lymph nodes are usually clearly defined.
• Solitary enhancing lesions should be biopsied
unless they are less than 5 mm or have clearly
nonenhancing internal septations.
• Breast MRI should not be used instead of
mammography; it is a complementary study to
other breast imaging modalities.
• Both mammography and USG have limitations
in the evaluation of the chest wall. MRI is able
to visualize the entirety of the chest wall.
Enhancement of the pectoralis and intercostal
muscles is indicative of chest wall invasion in
patients with a posterior breast tumor.
Breast MRI indications
• 1-Preoperative evaluation of patients
with newly diagnosed breast cancer:
• when combined with mammography
and clinical breast exam, has been
shown to provide sensitivity of 99% for
the preoperative assessment of the
local extent of disease in patients with
newly diagnosed breast cancer.
•
• The purpose of MRI is to detect the
presence of multifocal and multicentric
disease as well as to detect bulky residual
disease at the lumpectomy site in order to
allow directed re-excision.
• malignancies may enhance at much more
rapid initial rates than benign lesions.
• Breast cancer staging is based on the extent of
local-regional disease in the breast and axilla,
which has predictive value regarding the
patient's prognosis and dictates treatment
options.
• MRI sensitivity rates for the detection of
invasive breast cancer are estimated to be
as high as 95-100%.
•
Breast cancers are usually irregular in
shape and heterogeneous in their
enhancement on MRI.
• 2- evaluation of breast cancer patients
treated with neoadjuvant chemotherapy.
MRI has been used to monitor treatment
response to neoadjuvant chemotherapy in
patients with locally advanced cancer.
• Change in tumor vascularity/enhancement
appear to explain changes in functional
dynamic contrast assessment and can be
seen after only one cycle of chemotherapy.
• Neoadjuvant chemotherapy. Sagittal post
contrast fat suppressed T1W image prior to
chemotherapy shows an enhancing mass
correlating to a biopsy-proven invasive
ductal carcinoma (A). Following
chemotherapy, a comparable image shows
only a small area of residual enhancement
• 3- evaluation of patients with metastatic
axillary lymphadenopathy and an unknown
primary malignancy.
• 4- evaluation of breast cancer patients with
positive surgical margins following breast
conservation therapy.
• MRI can be useful in determining the extent
of residual disease when margins are
positive and the mammogram is not helpful.
Postsurgical MRI can demonstrate residual
malignant disease. The postoperative MRI shows
the seroma cavity on both the T2 images
•5- determination of silicone breast implant integrity.
(A) Retropectoral and (B) retroglandular
placement of implants on MRI. Sagittal T1weighted images of two different patients with
silicone implants.
• 6-breast cancer screening in high risk
women.
• 7- use of breast MRI as a problemsolving tool for equivocal
mammographic findings and for 3dimensional localization of a lesion
seen.
• 8- Evaluation of occult breast
cancer
• In patients with an occult primary
presenting with axillary
lymphadenopathy or Paget's disease,
MRI has been shown to identify the
primary in many patients, thus
allowing for conservative surgery
rather than mastectomy.
Detection of occult malignancy. This patient
had a positive axillary lymph node with a
negative clinical examination
• 9-small breast (MRI) is well suited to the
investigation of breast cancer by virtue of its
noninvasive nature and its multiplanar imaging
abilities.
• 10-Post surgical scar vs. recurrent tumor
• In cases where mammography and ultrasound
are inconclusive in patient suspected of
recurrent disease, MRI can be helpful.
• Breast tissue can show enhancement for up to
18 months following radiation therapy.
Invasive breast cancer visible on
T1-weighted image because of the
surrounding fat.
Cysts are bright on T2. In this mammogram
of the right breast (A), the dense tissues
obscure the cysts that are easily seen on
the T2-weighted MRI examination (B).
Blood in the ducts can be bright on T1.
This patient had a bloody nipple
discharge on the right. The blood in the
duct is bright on the precontrast T1
image.
• 11-Breast MRI has consistently been
found to detect additional
unsuspected malignancy within the
ipsilateral breast(in 10% to 27% of
patients).
12-Pectoral muscle tumor invasion.
.
• C. Inappropriate Use of Breast MRI
• 1. Screening of general population
• At present there is no data to support
the use of MRI as a screening tool.
• To date, there are no studies
demonstrating decreased mortality by
the use of MRI. Not all cancers seen
on mammography can be identified in
MRI.
• 2. Differentiation of benign & malignant
lesions
• Because of an overlap between the
enhancement and morphological
characteristics of benign and malignant
lesions, MRI cannot be used as a
substitute for biopsy.
Thank you